Immunogenicity and reactogenicity of heterologous and homologous mRNA-1273 and BNT162b2 vaccination: A multicenter non-inferiority randomized trial.
Saved in:
| Title: | Immunogenicity and reactogenicity of heterologous and homologous mRNA-1273 and BNT162b2 vaccination: A multicenter non-inferiority randomized trial. |
|---|---|
| Authors: | Janssen C; Service de Maladies Infectieuses, Centre Hospitalier Annecy Genevois, Annecy 74370, France.; Inserm, F-CRIN, I REIVAC/COVIREIVAC, France., Cachanado M; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint Antoine, Department of Clinical Pharmacology and Clinical Research Platform of East of Paris (Unité de Recherche Clinique (URCEST), Centre de Recherche Clinique (CRCEST), Centre de Ressources Biologiques (CRB.APHP-SU), Paris, France., Ninove L; Unité des Virus Emergents, UVE: Aix Marseille Univ, IRD 190, INSERM 1207, Marseille 13005, France., Lachatre M; Centre d'Investigations Cliniques (CIC 1417) Cochin Pasteur, AP-HP, Hôpital Cochin, Paris, France.; Inserm, F-CRIN, I REIVAC/COVIREIVAC, France., Michon J; Inserm, F-CRIN, I REIVAC/COVIREIVAC, France.; Service Des Maladies Infectieuses et Tropicales, Centre Hospitalier Universitaire, Caen 14000, France., Epaulard O; Inserm, F-CRIN, I REIVAC/COVIREIVAC, France.; Service des maladies Infectieuses, CHU Grenoble Alpes, CIC1406 Inserm - CHUGA - Université Grenoble Alpes, Grenoble, France., Maakaroun-Vermesse Z; Inserm, F-CRIN, I REIVAC/COVIREIVAC, France.; Centre de vaccination, CHU de Tours, CIC 1415 CHU de Tours, France., Chidiac C; Inserm, F-CRIN, I REIVAC/COVIREIVAC, France.; Service des Maladies Infectieuses et Tropicales GHN HCL - CIRI Équipe PH3ID - INSERM - U1111- UCBL Lyon 1 - CNRS - UMR5308 - ENS de Lyon, France., Laviolle B; Inserm, F-CRIN, I REIVAC/COVIREIVAC, France.; Univ Rennes, CHU Rennes, Inserm, CIC 1414 (Centre d'Investigation Clinique de Rennes, Service de Pharmacologie Clinique), Irset (Institut de Recherche en Santé, Environnement et Travail) UMR S 1085, Rennes F-35000, France., Aumaitre H; SMIT Perpignan - Infectious and Tropical Disease Unit, Perpignan Hospital Center, Perpignan, France., Assaf A; Inserm, F-CRIN, I REIVAC/COVIREIVAC, France.; CHU Lille, Service de Maladies Infectieuses, University Lille, CNRS, Inserm, CHU Lille, Institute Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille F-59000, France., Lacombe K; Inserm, F-CRIN, I REIVAC/COVIREIVAC, France.; IPLESP - AP-HP, Service des Maladies Infectieuses et Tropicales, Hôpital St Antoine, Sorbonne Université, Paris, France., Schmidt-Mutter C; Inserm, F-CRIN, I REIVAC/COVIREIVAC, France.; Centre d'Investigation Clinique CIC INSERM 1434, CHU de Strasbourg, France., Botelho-Nevers E; Inserm, F-CRIN, I REIVAC/COVIREIVAC, France.; Service d'infectiologie, CIC1408, CHU de Saint-Etienne, Saint-Etienne 42055, France.; Team GIMAP, CIRI, Inserm, U1111, CNRS, UMR530, Univ Lyon, Université Jean Monnet, F42023 Saint-Etienne., Briere M; Maison de la Médecine Préventive, Service de Médecine interne, Maladies Infectieuses, hématologie, Centre Hospitalier Bretagne Atlantique, 20, boulevard Maurice Guillaudot, Vannes 56000, France., Boisson T; Service de Médecine Interne, Centre Hospitalier Alpes Léman, Contamine Sur Arve, France., Loubet P; Inserm, F-CRIN, I REIVAC/COVIREIVAC, France.; Department of Tropical and Infectious Diseases, Virulence Bactérienne et Infection Chronique INSERM U1047, University Montpellier, CHU Nîmes, Nîmes, France., Bienvenu B; Inserm, F-CRIN, I REIVAC/COVIREIVAC, France.; Médecine Interne, Hôpital Saint Joseph, CEDEX 08, Marseille 13285, France., Bouchaud O; AP-HP, Service des Maladies Infectieuses et Tropicales, Hôpital Avicenne, Université Paris-13, Bobigny, France., Touati A; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint Antoine, Department of Clinical Pharmacology and Clinical Research Platform of East of Paris (Unité de Recherche Clinique (URCEST), Centre de Recherche Clinique (CRCEST), Centre de Ressources Biologiques (CRB.APHP-SU), Paris, France., Pereira C; Centre d'Investigations Cliniques (CIC 1417) Cochin Pasteur, AP-HP, Hôpital Cochin, Paris, France.; Inserm, F-CRIN, I REIVAC/COVIREIVAC, France., Rousseau A; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint Antoine, Department of Clinical Pharmacology and Clinical Research Platform of East of Paris (Unité de Recherche Clinique (URCEST), Centre de Recherche Clinique (CRCEST), Centre de Ressources Biologiques (CRB.APHP-SU), Paris, France., Berard L; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint Antoine, Department of Clinical Pharmacology and Clinical Research Platform of East of Paris (Unité de Recherche Clinique (URCEST), Centre de Recherche Clinique (CRCEST), Centre de Ressources Biologiques (CRB.APHP-SU), Paris, France., Montil M; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint Antoine, Department of Clinical Pharmacology and Clinical Research Platform of East of Paris (Unité de Recherche Clinique (URCEST), Centre de Recherche Clinique (CRCEST), Centre de Ressources Biologiques (CRB.APHP-SU), Paris, France., de Lamballerie X; Unité des Virus Emergents, UVE: Aix Marseille Univ, IRD 190, INSERM 1207, Marseille 13005, France., Simon T; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint Antoine, Department of Clinical Pharmacology and Clinical Research Platform of East of Paris (Unité de Recherche Clinique (URCEST), Centre de Recherche Clinique (CRCEST), Centre de Ressources Biologiques (CRB.APHP-SU), Paris, France.; Service de Pharmacologie, Sorbonne Université, Paris, France., Launay O; Centre d'Investigations Cliniques (CIC 1417) Cochin Pasteur, AP-HP, Hôpital Cochin, Paris, France.; Inserm, F-CRIN, I REIVAC/COVIREIVAC, France.; Faculté de Médecine, Inserm, CIC 1417, F CRIN I-REIVAC, Université de Paris, Paris, France. |
| Corporate Authors: | ARNCOMBI Study Group |
| Source: | EClinicalMedicine [EClinicalMedicine] 2022 Jun; Vol. 48, pp. 101444. Date of Electronic Publication: 2022 May 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: The Lancet Country of Publication: England NLM ID: 101733727 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2589-5370 (Electronic) Linking ISSN: 25895370 NLM ISO Abbreviation: EClinicalMedicine Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35582124 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Immunogenicity and reactogenicity of heterologous and homologous mRNA-1273 and BNT162b2 vaccination: A multicenter non-inferiority randomized trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Janssen+C%22">Janssen C</searchLink>; Service de Maladies Infectieuses, Centre Hospitalier Annecy Genevois, Annecy 74370, France.; Inserm, F-CRIN, I REIVAC/COVIREIVAC, France.<br /><searchLink fieldCode="AU" term="%22Cachanado+M%22">Cachanado M</searchLink>; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint Antoine, Department of Clinical Pharmacology and Clinical Research Platform of East of Paris (Unité de Recherche Clinique (URCEST), Centre de Recherche Clinique (CRCEST), Centre de Ressources Biologiques (CRB.APHP-SU), Paris, France.<br /><searchLink fieldCode="AU" term="%22Ninove+L%22">Ninove L</searchLink>; Unité des Virus Emergents, UVE: Aix Marseille Univ, IRD 190, INSERM 1207, Marseille 13005, France.<br /><searchLink fieldCode="AU" term="%22Lachatre+M%22">Lachatre M</searchLink>; Centre d'Investigations Cliniques (CIC 1417) Cochin Pasteur, AP-HP, Hôpital Cochin, Paris, France.; Inserm, F-CRIN, I REIVAC/COVIREIVAC, France.<br /><searchLink fieldCode="AU" term="%22Michon+J%22">Michon J</searchLink>; Inserm, F-CRIN, I REIVAC/COVIREIVAC, France.; Service Des Maladies Infectieuses et Tropicales, Centre Hospitalier Universitaire, Caen 14000, France.<br /><searchLink fieldCode="AU" term="%22Epaulard+O%22">Epaulard O</searchLink>; Inserm, F-CRIN, I REIVAC/COVIREIVAC, France.; Service des maladies Infectieuses, CHU Grenoble Alpes, CIC1406 Inserm - CHUGA - Université Grenoble Alpes, Grenoble, France.<br /><searchLink fieldCode="AU" term="%22Maakaroun-Vermesse+Z%22">Maakaroun-Vermesse Z</searchLink>; Inserm, F-CRIN, I REIVAC/COVIREIVAC, France.; Centre de vaccination, CHU de Tours, CIC 1415 CHU de Tours, France.<br /><searchLink fieldCode="AU" term="%22Chidiac+C%22">Chidiac C</searchLink>; Inserm, F-CRIN, I REIVAC/COVIREIVAC, France.; Service des Maladies Infectieuses et Tropicales GHN HCL - CIRI Équipe PH3ID - INSERM - U1111- UCBL Lyon 1 - CNRS - UMR5308 - ENS de Lyon, France.<br /><searchLink fieldCode="AU" term="%22Laviolle+B%22">Laviolle B</searchLink>; Inserm, F-CRIN, I REIVAC/COVIREIVAC, France.; Univ Rennes, CHU Rennes, Inserm, CIC 1414 (Centre d'Investigation Clinique de Rennes, Service de Pharmacologie Clinique), Irset (Institut de Recherche en Santé, Environnement et Travail) UMR S 1085, Rennes F-35000, France.<br /><searchLink fieldCode="AU" term="%22Aumaitre+H%22">Aumaitre H</searchLink>; SMIT Perpignan - Infectious and Tropical Disease Unit, Perpignan Hospital Center, Perpignan, France.<br /><searchLink fieldCode="AU" term="%22Assaf+A%22">Assaf A</searchLink>; Inserm, F-CRIN, I REIVAC/COVIREIVAC, France.; CHU Lille, Service de Maladies Infectieuses, University Lille, CNRS, Inserm, CHU Lille, Institute Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille F-59000, France.<br /><searchLink fieldCode="AU" term="%22Lacombe+K%22">Lacombe K</searchLink>; Inserm, F-CRIN, I REIVAC/COVIREIVAC, France.; IPLESP - AP-HP, Service des Maladies Infectieuses et Tropicales, Hôpital St Antoine, Sorbonne Université, Paris, France.<br /><searchLink fieldCode="AU" term="%22Schmidt-Mutter+C%22">Schmidt-Mutter C</searchLink>; Inserm, F-CRIN, I REIVAC/COVIREIVAC, France.; Centre d'Investigation Clinique CIC INSERM 1434, CHU de Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Botelho-Nevers+E%22">Botelho-Nevers E</searchLink>; Inserm, F-CRIN, I REIVAC/COVIREIVAC, France.; Service d'infectiologie, CIC1408, CHU de Saint-Etienne, Saint-Etienne 42055, France.; Team GIMAP, CIRI, Inserm, U1111, CNRS, UMR530, Univ Lyon, Université Jean Monnet, F42023 Saint-Etienne.<br /><searchLink fieldCode="AU" term="%22Briere+M%22">Briere M</searchLink>; Maison de la Médecine Préventive, Service de Médecine interne, Maladies Infectieuses, hématologie, Centre Hospitalier Bretagne Atlantique, 20, boulevard Maurice Guillaudot, Vannes 56000, France.<br /><searchLink fieldCode="AU" term="%22Boisson+T%22">Boisson T</searchLink>; Service de Médecine Interne, Centre Hospitalier Alpes Léman, Contamine Sur Arve, France.<br /><searchLink fieldCode="AU" term="%22Loubet+P%22">Loubet P</searchLink>; Inserm, F-CRIN, I REIVAC/COVIREIVAC, France.; Department of Tropical and Infectious Diseases, Virulence Bactérienne et Infection Chronique INSERM U1047, University Montpellier, CHU Nîmes, Nîmes, France.<br /><searchLink fieldCode="AU" term="%22Bienvenu+B%22">Bienvenu B</searchLink>; Inserm, F-CRIN, I REIVAC/COVIREIVAC, France.; Médecine Interne, Hôpital Saint Joseph, CEDEX 08, Marseille 13285, France.<br /><searchLink fieldCode="AU" term="%22Bouchaud+O%22">Bouchaud O</searchLink>; AP-HP, Service des Maladies Infectieuses et Tropicales, Hôpital Avicenne, Université Paris-13, Bobigny, France.<br /><searchLink fieldCode="AU" term="%22Touati+A%22">Touati A</searchLink>; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint Antoine, Department of Clinical Pharmacology and Clinical Research Platform of East of Paris (Unité de Recherche Clinique (URCEST), Centre de Recherche Clinique (CRCEST), Centre de Ressources Biologiques (CRB.APHP-SU), Paris, France.<br /><searchLink fieldCode="AU" term="%22Pereira+C%22">Pereira C</searchLink>; Centre d'Investigations Cliniques (CIC 1417) Cochin Pasteur, AP-HP, Hôpital Cochin, Paris, France.; Inserm, F-CRIN, I REIVAC/COVIREIVAC, France.<br /><searchLink fieldCode="AU" term="%22Rousseau+A%22">Rousseau A</searchLink>; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint Antoine, Department of Clinical Pharmacology and Clinical Research Platform of East of Paris (Unité de Recherche Clinique (URCEST), Centre de Recherche Clinique (CRCEST), Centre de Ressources Biologiques (CRB.APHP-SU), Paris, France.<br /><searchLink fieldCode="AU" term="%22Berard+L%22">Berard L</searchLink>; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint Antoine, Department of Clinical Pharmacology and Clinical Research Platform of East of Paris (Unité de Recherche Clinique (URCEST), Centre de Recherche Clinique (CRCEST), Centre de Ressources Biologiques (CRB.APHP-SU), Paris, France.<br /><searchLink fieldCode="AU" term="%22Montil+M%22">Montil M</searchLink>; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint Antoine, Department of Clinical Pharmacology and Clinical Research Platform of East of Paris (Unité de Recherche Clinique (URCEST), Centre de Recherche Clinique (CRCEST), Centre de Ressources Biologiques (CRB.APHP-SU), Paris, France.<br /><searchLink fieldCode="AU" term="%22de+Lamballerie+X%22">de Lamballerie X</searchLink>; Unité des Virus Emergents, UVE: Aix Marseille Univ, IRD 190, INSERM 1207, Marseille 13005, France.<br /><searchLink fieldCode="AU" term="%22Simon+T%22">Simon T</searchLink>; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint Antoine, Department of Clinical Pharmacology and Clinical Research Platform of East of Paris (Unité de Recherche Clinique (URCEST), Centre de Recherche Clinique (CRCEST), Centre de Ressources Biologiques (CRB.APHP-SU), Paris, France.; Service de Pharmacologie, Sorbonne Université, Paris, France.<br /><searchLink fieldCode="AU" term="%22Launay+O%22">Launay O</searchLink>; Centre d'Investigations Cliniques (CIC 1417) Cochin Pasteur, AP-HP, Hôpital Cochin, Paris, France.; Inserm, F-CRIN, I REIVAC/COVIREIVAC, France.; Faculté de Médecine, Inserm, CIC 1417, F CRIN I-REIVAC, Université de Paris, Paris, France. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22ARNCOMBI+Study+Group%22">ARNCOMBI Study Group</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101733727%22">EClinicalMedicine</searchLink> [EClinicalMedicine] 2022 Jun; Vol. 48, pp. 101444. <i>Date of Electronic Publication: </i>2022 May 12. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22The+Lancet%22">The Lancet </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101733727 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2589-5370 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225895370%22">25895370 </searchLink><i>NLM ISO Abbreviation: </i>EClinicalMedicine <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35582124 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.eclinm.2022.101444 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 101444 Titles: – TitleFull: Immunogenicity and reactogenicity of heterologous and homologous mRNA-1273 and BNT162b2 vaccination: A multicenter non-inferiority randomized trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Janssen C – PersonEntity: Name: NameFull: Cachanado M – PersonEntity: Name: NameFull: Ninove L – PersonEntity: Name: NameFull: Lachatre M – PersonEntity: Name: NameFull: Michon J – PersonEntity: Name: NameFull: Epaulard O – PersonEntity: Name: NameFull: Maakaroun-Vermesse Z – PersonEntity: Name: NameFull: Chidiac C – PersonEntity: Name: NameFull: Laviolle B – PersonEntity: Name: NameFull: Aumaitre H – PersonEntity: Name: NameFull: Assaf A – PersonEntity: Name: NameFull: Lacombe K – PersonEntity: Name: NameFull: Schmidt-Mutter C – PersonEntity: Name: NameFull: Botelho-Nevers E – PersonEntity: Name: NameFull: Briere M – PersonEntity: Name: NameFull: Boisson T – PersonEntity: Name: NameFull: Loubet P – PersonEntity: Name: NameFull: Bienvenu B – PersonEntity: Name: NameFull: Bouchaud O – PersonEntity: Name: NameFull: Touati A – PersonEntity: Name: NameFull: Pereira C – PersonEntity: Name: NameFull: Rousseau A – PersonEntity: Name: NameFull: Berard L – PersonEntity: Name: NameFull: Montil M – PersonEntity: Name: NameFull: de Lamballerie X – PersonEntity: Name: NameFull: Simon T – PersonEntity: Name: NameFull: Launay O IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2022 Jun Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 2589-5370 Numbering: – Type: volume Value: 48 Titles: – TitleFull: EClinicalMedicine Type: main |
| ResultId | 1 |